• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miRNA-301b-3p 通过靶向 CPEB3/EGFR 轴促进高级别卵巢浆液性肿瘤的迁移和侵袭。

miRNA-301b-3p accelerates migration and invasion of high-grade ovarian serous tumor via targeting CPEB3/EGFR axis.

机构信息

Department of Gynecology and obstetrics, the Fourth Hospital of Jinan, Jinan, Shandong, China.

Department of Laboratory Medicine, the Fourth Hospital of Jinan, Jinan, Shandong, China.

出版信息

J Cell Biochem. 2019 Aug;120(8):12618-12627. doi: 10.1002/jcb.28528. Epub 2019 Mar 4.

DOI:10.1002/jcb.28528
PMID:30834603
Abstract

High-grade ovarian serous carcinoma (HGS-OvCa), a type of ovarian cancer with poor prognosis due to distant metastasis, is urgently in need of new therapeutic targets. microRNAs (miRNAs), a class of small noncoding RNAs, perform significant roles in tumor progression. Mounting evidence has revealed the aberrant expression of miRNA in various cancers, one of which is HGS-OvCa. Present study planned to investigate that miRNA-301b-3p accelerates migration and invasion of high-grade ovarian serous tumor via targeting CPEB3/EGFR axis. Upregulation of miR-301b-3p was uncovered in HGS-OvCa tissues and cell lines, and was identified to be associated with metastasis. The Kaplan-Meier analysis confirmed the association of miR-301b-3p with poor prognosis of HGS-OvCa patients. Transwell assay validated the oncogenic effect of miR-301b-3p on migration and invasion of HGS-OvCa cells. Cytoplasmic polyadenylation element binding protein 3 (CPEB3) was then identified as a target of miR-301b-3p. It was also discovered that CPEB3 was downregulated in HGS-OvCa tissues and cell lines. The Spearman correlation curve presented the negative correlation of CPEB3 expression with miR-301b-3p. Furthermore, rescue assays proved that miRNA-301b-3p regulated the invasion and migration through CPEB3. Western blot and qRT-PCR analysis showed that miRNA-301b-3p induced epidermal growth factor receptor and downstream metastasis-related proteins, p38, and extracellular signal-regulated kinase 1/2 (ERK1/2), through CPEB3. To be concluded, these results indicated that miRNA-301b-3p accelerated migration and invasion of high-grade ovarian serous tumor via targeting CPEB3/EGFR axis.

摘要

高级别卵巢浆液性癌(HGS-OvCa)是一种预后不良的卵巢癌,其特征是远处转移,因此迫切需要新的治疗靶点。微小 RNA(miRNA)是一类小的非编码 RNA,在肿瘤进展中发挥重要作用。越来越多的证据表明,miRNA 在各种癌症中存在异常表达,其中之一就是 HGS-OvCa。本研究旨在探讨 miRNA-301b-3p 通过靶向 CPEB3/EGFR 轴加速高级别卵巢浆液性肿瘤的迁移和侵袭。研究发现 HGS-OvCa 组织和细胞系中存在 miR-301b-3p 的上调,且与转移相关。Kaplan-Meier 分析证实 miR-301b-3p 与 HGS-OvCa 患者的不良预后相关。Transwell 实验验证了 miR-301b-3p 对 HGS-OvCa 细胞迁移和侵袭的致癌作用。随后发现细胞质多聚腺苷酸化元件结合蛋白 3(CPEB3)是 miR-301b-3p 的靶标。还发现 CPEB3 在 HGS-OvCa 组织和细胞系中下调。Spearman 相关曲线显示 CPEB3 表达与 miR-301b-3p 呈负相关。此外,挽救实验证明 miR-301b-3p 通过 CPEB3 调节侵袭和迁移。Western blot 和 qRT-PCR 分析显示,miRNA-301b-3p 通过 CPEB3 诱导表皮生长因子受体和下游与转移相关的蛋白 p38 和细胞外信号调节激酶 1/2(ERK1/2)。综上所述,这些结果表明,miRNA-301b-3p 通过靶向 CPEB3/EGFR 轴加速高级别卵巢浆液性肿瘤的迁移和侵袭。

相似文献

1
miRNA-301b-3p accelerates migration and invasion of high-grade ovarian serous tumor via targeting CPEB3/EGFR axis.miRNA-301b-3p 通过靶向 CPEB3/EGFR 轴促进高级别卵巢浆液性肿瘤的迁移和侵袭。
J Cell Biochem. 2019 Aug;120(8):12618-12627. doi: 10.1002/jcb.28528. Epub 2019 Mar 4.
2
Mir-452-3p: A Potential Tumor Promoter That Targets the CPEB3/EGFR Axis in Human Hepatocellular Carcinoma.Mir-452-3p:一种靶向人类肝细胞癌中CPEB3/EGFR轴的潜在肿瘤促进因子。
Technol Cancer Res Treat. 2017 Dec;16(6):1136-1149. doi: 10.1177/1533034617735931. Epub 2017 Nov 5.
3
Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues.用于高级别浆液性卵巢癌组织中微小RNA定量的稳定表达参考小非编码RNA的鉴定
J Cell Mol Med. 2016 Dec;20(12):2341-2348. doi: 10.1111/jcmm.12927. Epub 2016 Jul 15.
4
LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression.长链非编码 RNA PTAR 通过竞争性结合 miR-101-3p 调控 ZEB1 表达促进浆液性卵巢癌中的 EMT 和侵袭转移。
Mol Cancer. 2018 Aug 11;17(1):119. doi: 10.1186/s12943-018-0870-5.
5
MiR-224 Executes a Tumor Accelerative Role during Hepatocellular Carcinoma Malignancy by Targeting Cytoplasmic Polyadenylation Element-Binding Protein 3.miR-224 通过靶向细胞质多聚腺苷酸化元件结合蛋白 3 在肝细胞癌恶性进展中发挥肿瘤促进作用。
Pharmacology. 2020;105(7-8):477-487. doi: 10.1159/000506711. Epub 2020 May 26.
6
CPEB3 overexpression caused by miR-106b-5p inhibition inhibits esophageal carcinoma in-vitro progression and metastasis.由miR-106b-5p抑制引起的CPEB3过表达抑制食管癌的体外进展和转移。
Anticancer Drugs. 2022 Apr 1;33(4):335-351. doi: 10.1097/CAD.0000000000001265.
7
miR-1236-3p represses the cell migration and invasion abilities by targeting ZEB1 in high-grade serous ovarian carcinoma.在高级别浆液性卵巢癌中,miR-1236-3p通过靶向ZEB1抑制细胞迁移和侵袭能力。
Oncol Rep. 2014 Apr;31(4):1905-10. doi: 10.3892/or.2014.3046. Epub 2014 Feb 24.
8
Targeting miR-21-3p inhibits proliferation and invasion of ovarian cancer cells.靶向miR-21-3p可抑制卵巢癌细胞的增殖和侵袭。
Oncotarget. 2016 Jun 14;7(24):36321-36337. doi: 10.18632/oncotarget.9216.
9
MiR-203a-3p regulates the biological behaviors of ovarian cancer cells through mediating the Akt/GSK-3β/Snail signaling pathway by targeting ATM.miR-203a-3p 通过靶向 ATM 调控 Akt/GSK-3β/Snail 信号通路对卵巢癌细胞的生物学行为进行调控。
J Ovarian Res. 2019 Jul 5;12(1):60. doi: 10.1186/s13048-019-0532-2.
10
Hypoxia induced microRNA-301b-3p overexpression promotes proliferation, migration and invasion of prostate cancer cells by targeting LRP1B.缺氧诱导 microRNA-301b-3p 过表达通过靶向 LRP1B 促进前列腺癌细胞的增殖、迁移和侵袭。
Exp Mol Pathol. 2019 Dec;111:104301. doi: 10.1016/j.yexmp.2019.104301. Epub 2019 Aug 21.

引用本文的文献

1
MicroRNAs, long non-coding RNAs, and circular RNAs and gynecological cancers: focus on metastasis.微小RNA、长链非编码RNA和环状RNA与妇科癌症:聚焦转移
Front Oncol. 2023 Oct 3;13:1215194. doi: 10.3389/fonc.2023.1215194. eCollection 2023.
2
Potential Association of Cytochrome P450 Copy Number Alteration in Tumour with Chemotherapy Resistance in Lung Adenocarcinoma Patients.肿瘤细胞色素 P450 拷贝数改变与肺腺癌患者化疗耐药的相关性研究。
Int J Mol Sci. 2023 Aug 29;24(17):13380. doi: 10.3390/ijms241713380.
3
Preparation, characterisation, and in vitro cancer-suppression function of RNA nanoparticles carrying miR-301b-3p Inhibitor.
携带 miR-301b-3p 抑制剂的 RNA 纳米颗粒的制备、表征及体外抑癌功能。
IET Nanobiotechnol. 2023 May;17(3):224-233. doi: 10.1049/nbt2.12120. Epub 2023 Mar 9.
4
Extracellular Vesicles-ceRNAs as Ovarian Cancer Biomarkers: Looking into circRNA-miRNA-mRNA Code.作为卵巢癌生物标志物的细胞外囊泡-ceRNAs:探究环状RNA-微小RNA-信使RNA编码
Cancers (Basel). 2022 Jul 13;14(14):3404. doi: 10.3390/cancers14143404.
5
Mechanism of miR-34a in the metabolism of extracellular matrix in fibroblasts of stress urinary incontinence via Nampt-mediated autophagy.miR-34a 通过 Nampt 介导的自噬在压力性尿失禁成纤维细胞细胞外基质代谢中的作用机制。
Cell Stress Chaperones. 2022 Jul;27(4):369-381. doi: 10.1007/s12192-022-01278-w. Epub 2022 Jun 6.
6
Transcriptomic analysis of patient plasma reveals circulating miR200c as a potential biomarker for high-grade serous ovarian cancer.患者血浆的转录组分析显示,循环miR200c是高级别浆液性卵巢癌的潜在生物标志物。
Gynecol Oncol Rep. 2021 Dec 2;39:100894. doi: 10.1016/j.gore.2021.100894. eCollection 2022 Feb.
7
MicroRNA-21-5p Reduces Hypoxia/Reoxygenation-Induced Neuronal Cell Damage through Negative Regulation of CPEB3.微小 RNA-21-5p 通过负向调控 CPEB3 减少低氧/复氧诱导的神经元细胞损伤。
Anal Cell Pathol (Amst). 2021 Dec 2;2021:5543212. doi: 10.1155/2021/5543212. eCollection 2021.
8
Integrated analysis of the functions and prognostic values of RNA-binding proteins in neuroblastoma.神经母细胞瘤中 RNA 结合蛋白功能与预后价值的综合分析。
PLoS One. 2021 Dec 8;16(12):e0260876. doi: 10.1371/journal.pone.0260876. eCollection 2021.
9
LINC01089 suppresses lung adenocarcinoma cell proliferation and migration via miR-301b-3p/STARD13 axis.LINC01089 通过 miR-301b-3p/STARD13 轴抑制肺腺癌细胞增殖和迁移。
BMC Pulm Med. 2021 Jul 19;21(1):242. doi: 10.1186/s12890-021-01568-6.
10
MicroRNA 320, an Anti-Oncogene Target miRNA for Cancer Therapy.微小RNA 320,一种用于癌症治疗的抗癌基因靶点微小RNA。
Biomedicines. 2021 May 23;9(6):591. doi: 10.3390/biomedicines9060591.